Applying Guideline Updates and Real-World Experience in CLL: Experts Review State-of-the-Art Evidence and Address Clinical Challenges

Download slides from a live CCO symposium in which expert faculty discuss optimal treatment plans for patients with CLL/SLL while considering adverse events biomarkers comorbidities and patient preferences.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

Supporters

Supported by educational grants from

AstraZeneca

BeiGene, Ltd.

Genentech, a member of the Roche Group

Janssen Biotech Pharmacyclics Abbvie